Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

New England Journal of Medicine - Tập 378 Số 24 - Trang 2288-2301 - 2018
Mark A. Socinski1, Robert M. Jotte2,3, Federico Cappuzzo4, F. Orlandi5, Daniil Stroyakovskiy6, Naoyuki Nogami7, Delvys Rodríguez‐Abreu8, Denis Moro‐Sibilot9, Christian A. Thomas10, Fabrice Barlési11, Gene Grant Finley12, Claudia Kelsch13, Anthony Lee13, Shelley Coleman13, Yu Deng13, Yijing Shen13, Marcin Kowanetz13, Pilar Garrido13, Alan Sandler13, Martin Reck14
1Florida Hospital Cancer Institute, Orlando
2Rocky Mountain Cancer Centers, Denver
3US Oncology, Houston
4Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy
5Instituto Nacional del Torax, Santiago, Chile
6Moscow City Oncology Hospital, Moscow
7National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
8Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
9Centre Hospitalier Universitaire de Grenoble Alpes, Grenoble
10New England Cancer Specialists, Scarborough, ME
11Aix Marseille University, Assistance Publique–Hôpitaux de Marseille, Marseille
12Allegheny Health Network Cancer Institute, Pittsburgh
13Genentech, South San Francisco, CA
14Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1056/NEJMoa061884

10.1093/annonc/mdw326

10.1056/NEJMoa1606774

10.1056/NEJMoa1801005

10.1158/1078-0432.CCR-12-1362

10.1038/nature14011

10.1016/S0140-6736(16)32517-X

10.1200/JCO.2017.35.15_suppl.9092

10.1056/NEJMoa1507643

10.1016/S0140-6736(15)01281-7

10.1200/JCO.2007.14.5466

10.1093/annonc/mdq020

10.1038/nrd1381

10.1006/cimm.1996.0139

Oyama T, 1998, J Immunol, 160, 1224, 10.4049/jimmunol.160.3.1224

10.1152/physrev.00038.2010

10.1038/nm.3541

10.1158/2326-6066.CIR-14-0053

10.1038/ncomms12624

10.1093/annonc/mdw217

10.1038/nri2506

10.1371/journal.pone.0007669

10.1038/nature10169

10.1084/jem.20140559

10.1016/j.semcancer.2017.12.002

10.1016/j.immuni.2013.07.012

10.1016/S0140-6736(16)00587-0

10.1016/j.jtho.2017.09.485

10.1002/sim.5642

10.1002/sim.5990

10.1200/JCO.2004.11.022

10.1093/annonc/mdx380.001

10.1200/JCO.2016.34.15_suppl.e20665

10.1158/2326-6066.CIR-16-0325

10.1200/JCO.2017.35.15_suppl.3038

10.1200/JCO.2016.71.9476

Cortinovis D, 2017, Ann Oncol, 28, 468, 10.1093/annonc/mdx380.016